EyePoint Other Long Term Liabilities (Quarterly) Analysis

EyePoint Plc (EYPT)

17.21 +0.13 (+0.76%) USD | NASDAQ | Feb 24, 10:39

View Other Long Term Liabilities (Quarterly) for EYPT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	Upgrade
Ocular Therapeutix, Inc.	Upgrade
Viking Therapeutics, Inc.	--
Janux Therapeutics, Inc.	--
Tango Therapeutics, Inc.	--